Area of research
Endocrinology, Diabetes and Metabolism · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Apatinib and Thyroid cancer, with related work in Cancer, Anaplastic thyroid cancer, Sorafenib. Notable publications include 'Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer', 'Nanomedicine for renal cell carcinoma: imaging, treatment and beyond', and 'Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer'.
RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer
Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy
Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial.
Donafenib in Locally Advanced/Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (DIRECTION)
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer